Colon to Rectum

J Crohns Colitis. 2022;16(8):1187–96

Dong C, Chan SSM, Jantchou P, Racine A, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tjønneland A, Kyrø C, Bueno de Mesquita B, Kaaks R, Katzke VA, Bergman MM, Boeing H, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, Sánchez MJ, Grip O, Lindgren S, Luben R, Huybrechts I, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F

Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study


Background and aims: The authors aimed to investigate the association between protein intake and risk of inflammatory bowel disease (IBD) in the European Prospective Investigation into Cancer and Nutrition.
Methods: A total of 413,593 participants from 8 European countries were included. Dietary data were collected at baseline from validated food frequency questionnaires. Dietary data were calibrated to correct errors in measures related to each country-specific questionnaire. Associations between proteins (total, animal, and vegetable) or food sources of animal proteins, and IBD risk were estimated by Cox proportional hazard models.
Results: After a mean follow-up of 16 years, 177 patients with Crohn’s disease (CD) and 418 with ulcerative colitis (UC), were identified. There was no association between total protein, animal protein, or vegetable protein intakes and CD or UC risks. Total meat and red meat intakes were associated with UC risk (hazard ratio for the 4th vs. 1st quartile = 1.40, 95% confidence interval [CI]: 0.99–1.98, ptrend = 0.01; and 1.61, 95% CI: 1.10–2.36, ptrend = 0.007, respectively). There was no association between other food sources of animal protein (processed meat, fish, shellfish, eggs, poultry) and UC. No association was found between food sources of animal proteins and CD risk.

Conclusions: Meat and red meat consumptions are associated with higher risks of ulcerative colitis. These results support dietary counseling of low meat intake in people at high-risk of inflammatory bowel disease.

Prof. Dr. F. Carbonnel, Department of Gastroenterology, University Hospital of Bicêtre, Le Kremlin-Bicêtre, France,
E-Mail: fcarbonnel7@gmail.com

DOI: 10.1093/ecco-jcc/jjac054

Back to overview

this could be of interest:

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from 3 phase 3, multicenter, double-blind, randomized trials

Lancet. 2022;399(10341):2113–28

Computer-aided detection improves adenomas per colonoscopy for screening and surveillance colonoscopy: A randomized trial

Gastroenterology. 2022;163(3):732–41

More articles on the topic